| Catherine D Davis, PA/AA | |
|
624 Bellgrove Pt, Macon, GA 31220-7621 | |
| (478) 731-4009 | |
| Not Available |
| Full Name | Catherine D Davis |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology Assistant |
| Experience | 27 Years |
| Location | 624 Bellgrove Pt, Macon, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306814249 | NPI | - | NPPES |
| 100000477E | Medicaid | GA | |
| P00097133 | Other | GA | PALMETTO GBA |
| 100000477C | Medicaid | GA | |
| 100000477F | Medicaid | GA | |
| 100000477G | Medicaid | GA | |
| 580628385 | Other | GA | TRICARE |
| 391018 | Other | GA | WELLCARE |
| P00422622 | Other | GA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 002988 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Coliseum Medical Centers, Llc, Dba | Macon, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Anesthesia Llc | 2163837972 | 155 |
News Archive
Asthma affects almost 1 in 10 children in the U.S. and is a leading cause of emergency room visits and hospitalizations in preschoolers. According to new research from Duke Health and collaborators, symptoms may be worse for children ages 2 to 5 who are overweight.
Findings from a recent real-world clinical study indicate that relatives of people with recent-onset psychosis benefit from supported self-management interventions to help with outcomes such as distress and negative feelings around caregiving.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that while Amgen/Stiefel/Pfizer's Enbrel is the most popular biologic across all lines of therapy for psoriasis treatment in newly diagnosed patients, Abbott's Humira is gaining increasing use as a first-line biologic at Enbrel's expense.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first patient has been enrolled in E-Tryton Italy, a registry study of the company's Tryton Side Branch Stent System.
› Verified 7 days ago
| Entity Name | Anesthesia Associates Of Macon Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083720478 PECOS PAC ID: 5799698601 Enrollment ID: O20031107000003 |
News Archive
Asthma affects almost 1 in 10 children in the U.S. and is a leading cause of emergency room visits and hospitalizations in preschoolers. According to new research from Duke Health and collaborators, symptoms may be worse for children ages 2 to 5 who are overweight.
Findings from a recent real-world clinical study indicate that relatives of people with recent-onset psychosis benefit from supported self-management interventions to help with outcomes such as distress and negative feelings around caregiving.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that while Amgen/Stiefel/Pfizer's Enbrel is the most popular biologic across all lines of therapy for psoriasis treatment in newly diagnosed patients, Abbott's Humira is gaining increasing use as a first-line biologic at Enbrel's expense.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first patient has been enrolled in E-Tryton Italy, a registry study of the company's Tryton Side Branch Stent System.
› Verified 7 days ago
| Entity Name | American Anesthesiology Associates Of Georgia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528068673 PECOS PAC ID: 7618934779 Enrollment ID: O20041210000442 |
News Archive
Asthma affects almost 1 in 10 children in the U.S. and is a leading cause of emergency room visits and hospitalizations in preschoolers. According to new research from Duke Health and collaborators, symptoms may be worse for children ages 2 to 5 who are overweight.
Findings from a recent real-world clinical study indicate that relatives of people with recent-onset psychosis benefit from supported self-management interventions to help with outcomes such as distress and negative feelings around caregiving.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that while Amgen/Stiefel/Pfizer's Enbrel is the most popular biologic across all lines of therapy for psoriasis treatment in newly diagnosed patients, Abbott's Humira is gaining increasing use as a first-line biologic at Enbrel's expense.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first patient has been enrolled in E-Tryton Italy, a registry study of the company's Tryton Side Branch Stent System.
› Verified 7 days ago
| Entity Name | Guardian Medical Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255786521 PECOS PAC ID: 8325347735 Enrollment ID: O20160505001064 |
News Archive
Asthma affects almost 1 in 10 children in the U.S. and is a leading cause of emergency room visits and hospitalizations in preschoolers. According to new research from Duke Health and collaborators, symptoms may be worse for children ages 2 to 5 who are overweight.
Findings from a recent real-world clinical study indicate that relatives of people with recent-onset psychosis benefit from supported self-management interventions to help with outcomes such as distress and negative feelings around caregiving.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that while Amgen/Stiefel/Pfizer's Enbrel is the most popular biologic across all lines of therapy for psoriasis treatment in newly diagnosed patients, Abbott's Humira is gaining increasing use as a first-line biologic at Enbrel's expense.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first patient has been enrolled in E-Tryton Italy, a registry study of the company's Tryton Side Branch Stent System.
› Verified 7 days ago
| Entity Name | Peach State Anesthesia Partners, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134751191 PECOS PAC ID: 8527496777 Enrollment ID: O20200321000409 |
News Archive
Asthma affects almost 1 in 10 children in the U.S. and is a leading cause of emergency room visits and hospitalizations in preschoolers. According to new research from Duke Health and collaborators, symptoms may be worse for children ages 2 to 5 who are overweight.
Findings from a recent real-world clinical study indicate that relatives of people with recent-onset psychosis benefit from supported self-management interventions to help with outcomes such as distress and negative feelings around caregiving.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that while Amgen/Stiefel/Pfizer's Enbrel is the most popular biologic across all lines of therapy for psoriasis treatment in newly diagnosed patients, Abbott's Humira is gaining increasing use as a first-line biologic at Enbrel's expense.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first patient has been enrolled in E-Tryton Italy, a registry study of the company's Tryton Side Branch Stent System.
› Verified 7 days ago
| Entity Name | Piedmont Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700474244 PECOS PAC ID: 2163837972 Enrollment ID: O20210208002823 |
News Archive
Asthma affects almost 1 in 10 children in the U.S. and is a leading cause of emergency room visits and hospitalizations in preschoolers. According to new research from Duke Health and collaborators, symptoms may be worse for children ages 2 to 5 who are overweight.
Findings from a recent real-world clinical study indicate that relatives of people with recent-onset psychosis benefit from supported self-management interventions to help with outcomes such as distress and negative feelings around caregiving.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that while Amgen/Stiefel/Pfizer's Enbrel is the most popular biologic across all lines of therapy for psoriasis treatment in newly diagnosed patients, Abbott's Humira is gaining increasing use as a first-line biologic at Enbrel's expense.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first patient has been enrolled in E-Tryton Italy, a registry study of the company's Tryton Side Branch Stent System.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Catherine D Davis, PA/AA 624 Bellgrove Pt, Macon, GA 31220-7621 Ph: (478) 731-4009 | Catherine D Davis, PA/AA 624 Bellgrove Pt, Macon, GA 31220-7621 Ph: (478) 731-4009 |
News Archive
Asthma affects almost 1 in 10 children in the U.S. and is a leading cause of emergency room visits and hospitalizations in preschoolers. According to new research from Duke Health and collaborators, symptoms may be worse for children ages 2 to 5 who are overweight.
Findings from a recent real-world clinical study indicate that relatives of people with recent-onset psychosis benefit from supported self-management interventions to help with outcomes such as distress and negative feelings around caregiving.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that while Amgen/Stiefel/Pfizer's Enbrel is the most popular biologic across all lines of therapy for psoriasis treatment in newly diagnosed patients, Abbott's Humira is gaining increasing use as a first-line biologic at Enbrel's expense.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first patient has been enrolled in E-Tryton Italy, a registry study of the company's Tryton Side Branch Stent System.
› Verified 7 days ago
Mrs. Dena D Mckenna, PAAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 777 Hemlock St, Msc10, Macon, GA 31201 Phone: 478-633-1000 | |
Mr. Ryan C. Wallentine, PA-AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 380 Hospital Dr, Suite 410, Macon, GA 31217 Phone: 478-746-5644 Fax: 478-745-4849 | |
Dr. Ge Ye, DPM Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2180 Vineville Ave, Macon, GA 31204 Phone: 478-742-3631 | |
Eric S Curtright, PA-AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 777 Hemlock St, Macon, GA 31201 Phone: 866-507-5244 Fax: 855-851-4405 | |
Mrs. Christie Huskey Gibson, PA-AC Anesthesiologist Assistant Medicare: Not Enrolled in Medicare Practice Location: 380 Hospital Dr, Suite 410, Macon, GA 31217 Phone: 478-746-5644 Fax: 478-745-4849 | |
Athena Jmullins Mullins, PA-AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 777 Hemlock St, Macon, GA 31201 Phone: 866-507-5244 Fax: 855-851-4405 | |
Shilpa A Rege, PA-AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 380 Hospital Dr, Suite 410, Macon, GA 31217 Phone: 478-746-5644 |